#Medtech Market in Europe

[foxxfin]

Dive into the Medtech Market in Europe with FOXX. Discover key players, emerging trends, and opportunities in the medical technology sector across Europe, empowering your business with valuable insights and analytics.

[deshpandeisha]

How Ablation Systems Work: Mechanisms and Techniques Explained

The global ablation systems market size was USD 5.75 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.6% during the forecast period. Increasing integration of ablation systems with imaging technologies and rising adoption of robotics and navigation technologies are major factors driving market revenue growth.

The Ablation Systems Market added by Emergen Research offers a comprehensive analysis of the recent advancements in the Ablation Systems industry and trends driving the growth of the market. It is an investigative study covering analysis of market drivers, restraints, challenges, threats, and growth prospects in the global Ablation Systems market. The global Ablation Systems market report is a methodical research of the Ablation Systems market done by extensive primary and secondary research. The fundamental purpose of the Ablation Systems market report is to offer an accurate and strategic analysis of the Ablation Systems business sphere.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/2557

Competitive Terrain:

The global Ablation Systems industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Medtronic, Johnson & Johnson, Abbott, Boston Scientific Corporation, AngioDynamic, Olympus, Smith+Nephew, Stryker, Dornier MedTech, and Cynosure, LLC

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Ablation Systems market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Ablation Systems market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Ablation Systems market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/2557

Market Segmentations of the Ablation Systems Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Ablation Systems market on the basis of product, application, and region:

Segments Covered in this report are:

Device Technology Outlook (Revenue, USD Billion; 2019-2032)

Radiofrequency (RF) Devices

Ultrasound Devices

Others

Application Outlook (Revenue, USD Billion; 2019-2032)

Cancer Treatment

Ophthalmologic Treatment

Urological Treatment

Others

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals & Clinics

Ambulatory Surgical Centers (ASCs)

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/ablation-systems-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/2557

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market

[lsieurope]

Lessons from Building & Scaling Medtech Ventures Through Challenging Market Conditions 

At LSI Europe ‘23, a panel of industry leaders gathered to discuss the present and future of the medtech market. With over 120 years of medtech experience, industry veterans shared their unique perspectives on the shifting landscape, offering valuable insights for entrepreneurs and medical device investors.

Learn More: https://www.lsieuropesummit.com/news/lessons-from-building-scaling-medtech-ventures-through-challenging-market-conditions-insights-from-lsi-europe-23 

[janetushar1]

Disposable Ureteroscope Market to Hit $6215.90 Million by 2032

The global Disposable Ureteroscope Market was valued at USD 1990.08 Million in 2024 and it is estimated to garner USD 6215.90 Million by 2032 with a registered CAGR of 15.3% during the forecast period 2024 to 2032.

The report throws light on the competitive scenario of the global Disposable Ureteroscope Market to know the competition at global levels. Market experts also provided the outline of each leading player of the global Disposable Ureteroscope Market for the market, considering the key aspects such as the areas of operation, production, and product portfolio. In addition, the companies in the report are studied based on vital factors such as company size, market share, market growth, revenue, production volume, and profit.

The global Disposable Ureteroscope Market is fragmented with various key players. Some of the key players identified across the value chain of the global Disposable Ureteroscope Market include Boston Scientific Corporation, Richard Wolf GmbH, Olympus Corporation, Fujifilm Holdings Corporation, Karl Storz GmbH, Smith & Nephew Inc., Pentax Medical, Elmed Electronics & Medical Systems S.A., Dornier MedTech, OPCOM, AED.MD and others. etc. Considering the increasing demand from global markets various new entries are expected in the Disposable Ureteroscope Market at regional as well as global levels.

Download Disposable Ureteroscope Market Sample Report PDF: https://www.vantagemarketresearch.com/disposable-ureteroscope-market-1690/request-sample

Top Competitors:

Boston Scientific Corporation, Richard Wolf GmbH, Olympus Corporation, Fujifilm Holdings Corporation, Karl Storz GmbH, Smith & Nephew Inc., Pentax Medical, Elmed Electronics & Medical Systems S.A., Dornier MedTech, OPCOM, AED.MD and others.

Understanding the Industry's Growth, has released an Updated report on the Disposable Ureteroscope Market. The report is mixed with crucial market insights that will support the clients to make the right business decisions. This research will help new players in the global Disposable Ureteroscope Market to sort out and study market needs, market size, and competition. The report provides information on the supply and market situation, the competitive situation and the challenges to the market growth, the market opportunities, and the threats faced by the major players.

Regional Analysis

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/disposable-ureteroscope-market-1690/0

Full Analysis Of The Disposable Ureteroscope Market:

Key findings and recommendations point to vital progressive industry trends in the global Disposable Ureteroscope Market, empowering players to improve effective long-term policies.

The report makes a full analysis of the factors driving the development of the market.

Analyzing the market opportunities for stakeholders by categorizing the high-growth divisions of the market.

Questions answered in the report

-Who are the top five players in the global Disposable Ureteroscope Market?

-How will the global Disposable Ureteroscope Market change in the next five years?

-Which product and application will take the lion's share of the global Disposable Ureteroscope Market?

-What are the drivers and restraints of the global Disposable Ureteroscope Market?

-Which regional market will show the highest growth?

-What will be the CAGR and size of the global Disposable Ureteroscope Market during the forecast period?

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/disposable-ureteroscope-market-1690

Reasons to Purchase this Disposable Ureteroscope Market Report:

-Analysis of the market outlook on current trends and SWOT analysis.

-The geographic and country level is designed to integrate the supply and demand organizations that drive industry growth.

-Disposable Ureteroscope Industry dynamics along with market growth opportunities in the coming years.

-Disposable Ureteroscope Market value (million USD) and volume (million units) data for each segment and sub-segment.

1 year consulting for analysts along with development data support in Excel. Competitive landscape including market share of major players along with various projects and strategies adopted by players in the last five years.

Market segmentation analysis including qualitative and quantitative analysis including the impact on financial and non-economic aspects.

Complete company profiles that include performance presentations, key financial overviews, current developments, SWOT analyzes and strategies used by major Disposable Ureteroscope Market players.

Check Out More Reports

Global Surgical Equipments Market:  Report Forecast by 2032

Global Cables and Accessories Market: Report Forecast by 2032

Global Bakery Processing Equipment Market: Report Forecast by 2032

Global Silicon Photomultipliers Market: Report Forecast by 2032

Global Exoskeleton Market: Report Forecast by 2032

[credenceresearchdotblog]

The global demand for shock wave therapy was valued at USD 1186.5 Million in 2022 and is expected to reach USD 2069.31 Million in 2030, growing at a CAGR of 7.2% between 2023 and 2030.Shock wave therapy, a non-invasive treatment modality, has gained considerable traction in the medical field over recent years. This innovative approach, primarily used for musculoskeletal disorders, has expanded into various therapeutic areas, presenting promising opportunities in the healthcare market. This article explores the current landscape of the shock wave therapy market, recent trends, technological advancements, and future prospects.

Browse the full report at https://www.credenceresearch.com/report/shock-wave-therapy-market

Understanding Shock Wave Therapy

Shock wave therapy involves the application of acoustic waves to targeted areas of the body to promote healing and reduce pain. The therapy utilizes high-energy shock waves to stimulate cellular repair and regeneration, alleviate inflammation, and enhance tissue repair. It is commonly employed for treating conditions such as plantar fasciitis, tendinitis, and calcific shoulder tendinopathy, among others.

Market Overview and Growth Drivers

The global shock wave therapy market has been experiencing robust growth, driven by several key factors:

1. Rising Prevalence of Musculoskeletal Disorders: An increase in the incidence of musculoskeletal disorders due to aging populations and active lifestyles has boosted the demand for effective and non-invasive treatment options like shock wave therapy.

2. Growing Awareness and Adoption: Increasing awareness among patients and healthcare providers about the benefits of shock wave therapy has led to its wider acceptance and adoption. The therapy's non-invasive nature, coupled with its potential for quicker recovery times, has contributed to its popularity.

3. Technological Advancements: Continuous advancements in shock wave therapy technology have led to the development of more efficient and precise devices. Innovations such as focused shock wave therapy and radial shock wave therapy have enhanced the efficacy of treatments and expanded their applicability.

4. Expanding Applications: Initially used primarily for musculoskeletal conditions, shock wave therapy has found applications in other areas such as urology (for treating kidney stones) and dermatology (for treating cellulite and scars). This diversification has opened new revenue streams and market opportunities.

Key Players

Dornier MedTech

Shockwave Medical Inc

BTL Industries

EDAP TMS

Boston Scientific Corporation

Bio-Med Inc

Inceler Medikal Co. Ltd

Karl Storz SE & Co. KG

EMS Dolorclast

Others

Segmentation

By Technology

Electrohydraulic Shock Wave Therapy (ESWT)

Electromagnetic Shock Wave Therapy (ESWT)

Piezoelectric Shock Wave Therapy

By Application

Orthopedic Conditions

Urology

Cardiology

Dermatology

Physiotherapy and Sports Medicine

Veterinary Medicine

By End-User

Hospitals

Clinics and Rehabilitation Centers

Sports and Fitness Centers

Veterinary Clinics

Home Use Devices

By Type of Shock Wave

Focused Shock Waves

Radial Shock Waves

Low-Energy Shock Waves

High-Energy Shock Waves

By Patient Age Group

Pediatric

Adult

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/shock-wave-therapy-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[secretofresearch]

The Emissions Trading Market is Moving Towards Sustainability

Emissions trading enables participants to stay within the defined cap through trading of carbon credits. The regulated entities that emit less than their allowance can sell the extra allowances (carbon credits) as per their needs, making the whole process very flexible and cost-effective. With growing concerns around environmental sustainability and tightening regulations, emissions trading has emerged as an efficient tool for incentivizing investments in cleaner technologies and driving down emissions. The global Emissions Trading Market is expected to exhibit a CAGR of 6.8% over the forecast period of 2024 to 2031.Key TakeawaysKey players operating in the Emissions Trading Market are Johnson & Johnson Services, Inc., 3M, Baxter, Coloplast A/S, Integra LifeSciences, Medtronic, Omeza, Cardinal Health, Bactiguard AB, Noventure, Essity, Schulke & Mayr GmbH, Smith & Nephew Plc., Convatec Group PLC, SANUWAVE and SANUWAVE Health, Inc., EO2 Concepts, Wound Care Advantage, LLC., Healthium Medtech Limited, Arch Therapeutics, Inc., Hydrofera, Sanara MedTech Inc., Axio Biosolutions Pvt Ltd., and Gentell, Inc. Major players are focusing on forming strategic partnerships and collaborations to develop advanced carbon credit trading platforms. The Emissions Trading Market Demand is witnessing significant due to strict regulations and incentives towards reducing industrial emissions. Growing awareness about environmental sustainability is encouraging more organizations to participate in emissions trading programs. The market is also benefiting from involvement of large corporates aiming to achieve carbon neutrality through carbon offsetting.Market Key TrendsOne of the key trends gaining traction in the emissions trading market is the transition towards digital marketplaces and blockchain-based carbon trading platforms. Blockchain offers advantages like transparency, security and automation in carbon credit transactions. It facilitates seamless peer-to-peer trading of emission allowances and offsets between regulated entities and project developers. Major players are making investments in distributed ledger technologies to modernize existing cap-and-trade schemes and attract more participants to carbon markets. The shift towards blockchain-based infrastructure is expected to boost overall efficiency, drive higher trading volumes and uphold integrity in the carbon credit distribution process.Porter’s AnalysisThreat of new entrants: High capital requirement and stringent regulations make entry difficult for new players. Bargaining power of buyers: Large buyers can negotiate better prices due to their scale of operation.Bargaining power of suppliers: Suppliers have low bargaining power due to availability of substitutes.Threat of new substitutes: Alternate technologies for carbon capture pose threat of substitution.Competitive rivalry: Intense competition exists among existing players to gain market share.Geographical concentration: The emissions trading market in Europe accounts for over 80% share in terms of value currently, primarily driven by stringent emission reduction targets.Get more insights on Emissions Trading MarketAbout Author:Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[lifesciencemarketresearch]

Data Reveals That APAC's Medtech Market is Poised for Explosive Growth

The Asia-Pacific (APAC) region is rapidly emerging as a powerhouse in the global medtech market. According to our Global Market Analysis and Projections (MAP) Database, APAC is the second largest regional medtech market, boasting an estimated market size of $131 billion in 2023. This impressive figure is made more notable by the region’s rapid growth, with our medtech market intelligence team projecting APAC to experience nearly double the compound annual growth rate (CAGR) of both the United States and Europe. Specifically, APAC is projected to grow at a robust CAGR of 8.4% from 2023 to 2028. For more information visit https://www.4shared.com/photo/dfpZFs2uge/Data_Reveals_That_APACs_Medtec.html

[thebusinessmagnate]

Joerg Dreisewerd: Pioneering Operations and Expansions of World-Class Medical Equipment and Consumables at SARSTEDT in Brazil

The Business Magnate. Joerg Dreisewerd, Managing Director (Brazil) and Regional Manager (Latin America), SARSTEDT. A German-based medical equipment and consumables manufacturer and distributor, SARSTEDT manufactures cutting-edge and world-class equipment and consumables for the Medical or MedTech industries. Such manufacturing industries in the medical sector design different medical equipment and a diverse range of products for hospitals, research institutes, academic institutions, industrial facilities, and surgical environments. The manufactured products and equipment are used to diagnose, monitor, and treat diseases and other medical conditions. In this article, we will be shedding light on SARSTEDT’s first South American branch located in Brazil, and how its current Managing Director – Joerg Dreisewerd, initiated and is leading operations and expansions in Latin America. Through Joerg’s impactful strategies and implementations in achieving company goals and visions as well as pioneering operations in medical supplies in Brazil, the Managing Director has successfully positioned the firm as a global manufacturer and healthcare solutions supplier. 

SARSTEDT – Company Overview:

SARSTEDT Group – the medical equipment and consumables manufacturer and distributor, is a German-based company with its head office established in Nümbrecht, North Rhine-Westphalia, Germany. The company was founded in 1961 by Walter Sarstedt who laid the foundation for this now renowned and globally recognized family business. SARSTEDT Group has over 15 production sites all across the globe in Europe, North America, South America, and Australia. The company opened its first Latin American branch in 1998 in Sao Paulo, Brazil, South America, and this expansion to Brazil was yet another successful milestone completed by the company in that year following Europe in 1971, the US in 1973, and Australia in 1991. The SARSTEDT Group, a healthcare industry leader in Brazil commenced its sales operations in what is now the world’s largest health market in in the Latin American country. 

SARSTEDT Products Manufactured and Distributed: 

The worldwide partner in Medicine and Science – SARSTEDT innovates the type of medical and laboratory products and other equipment, establishing a goal to move people forward. The company is one of the leading suppliers in the industry and develops, produces, and sells equipment and consumables to markets all around the globe. The various equipment and consumables manufactured are all state-of-the-art, technology-integrated, safe, high-quality, and high-performance products. SARSTEDT’s medical equipment in Brazil are categorized from Diagnostics (pre-analytical processes), Laboratory (solutions for molecular biology, biochemistry, cell biology, and more), and Clinic and Transfusion (clinical care), to Laboratory Automation (pre&post-analytical processes in clinical and microbiology areas). The various products developed and designed in each category will be mentioned below. 

Diagnostics – products for clinics, doctor’s offices, medical laboratories, and blood banks. Multi-safe Disposal Boxes and Erythrocyte Sedimentation Rate Devices. Collecting, sampling, and storing material samples like saliva, blood, stool, and urine are also available in Sample Collection Systems/Products.

Laboratory – for applications in molecular biology, biochemistry, and cell biology. Following certified SARSTEDT quality standards like PCR Performance Tested, Biosphere ® plus, TC-Tested, and Cryo Performance Tested, the products manufactured and designed for clean room conditions and automated production processes are Reagent and Centrifuge Tubes, The Multiply ® PCR, Molecular Biology, Micro Screw Tubes and Reaction Vessels, Liquid Handling (transfer pipettes, serological pipettes, and pipette tips), Cell and Tissue Culture Products, General Laboratory Items, DNA-free Forensic Swabs, Stands, Storage Boxes, Air Samplers, Table Centrifuges with Swing-Out Motor, Mixing Systems/Devices. 

Clinic and Transfusion – for clinical care and transfusion product segments, the products designed in this category are Urine Drainage Measuring Systems/Products, Hygiene Utensils, Warming Devices of the SAHARA product group, Sterile Closing and Stripping Devices of Blood Bag Tubes. 

Laboratory Automation – for pre and post-analytical processes in clinical and microbiological laboratories in Sample Feeding, Sample Identification, Decapping of Samples, Aliquoting, Recapping, Sorting, Distributing, and Archiving. The products manufactured and designed are Tube Labelers, Tempus600 Sample Transport System, Compact Sorters, Modular Pre and Post-Analytical Systems/Products, and the S4DX System.

Joerg Dreisewerd – The Man Pioneering and Leading Brazil’s Operations:

Joerg Dreisewerd is the Managing Director at SARSTEDT Group’s Brazil operation branch and also Latin America’s Regional Manager. Joerg has a Bachelor’s in Business Administration from the University of Applied Scinces for Business (FHDW) and was awarded best student in class during his MBA in Business Management from FGV – Fundação Getulio Vargas. The Managing Director started his career as Project Manager and later took on his current role at SARSTEDT Group Brazil in 2017. Joerg has worked in the healthcare industry for 15 years, and at SARSTEDT Group in Latin America oversaw a range of diverse responsibilities from company restructuring, turnarounds, and strategizing and implementing ESG actions in all three large, medium, and small businesses in the region. 

Initiating and leading SARSTEDT Group’s operations in Brazil, Joerg helped expand the the company’s position as a globally recognized manufacturer and distributor of hospital and laboratory equipment and consumables. By offering value-added products for customers, partners, and stakeholders of the management, Joerg envisions improving healthcare services and products regarding safety and quality. 

Joerg Dreisewerd’s Accolades from HarvardX:

Certification in “Improving Global health: Focusing on Quality and Safety”.

Certification in “LEAD1x: Exercising Leadership: Foundational Principles”. 

SARSTEDT Group’s Achievements Under Joerg Dreisewerd’s Leadership:

Joerg helped facilitate an organizational and cultural transformational transition of the Brazil branch from a centralized management to a modern governance structure. This led the company to be awarded the “Selo Paulista de Diversidade” in 2022 “Great Place to Work” in 2023 and 2024. 

The Managing Director helped the company position itself as medical solutions supplier withing the country’s main healthcare groups and for this SARSTEDT was awarded the “Top 3 Laboratory Supplier Hospital Albert Einstein Group” in 2019, 2020, 2021, and 2023. 

The “Best Laboratory Supplier of Grupo Fleury” was also awarded from 2021 – 2023.

Awarded the “Premio ECO 2023” by the Amcham São Paulo – American chamber of commerce, for Joerg’s implementation of ESG strategies and actions that established SARSTEDT as a pioneer in a Circular economy Project for pre-analytical healthcare consumables called – Caixa Magica (Magic Box).

Visit More : https://thebusinessmagnate.com/joerg-dreisewerd-pioneering-operations-and-expansions-of-world-class-medical-equipment-and-consumables-at-sarstedt-in-brazil/

[healthcaremarketanalysis]

Urology Devices Market worth $48.6 billion by 2028

Urology Devices Market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028.

Download an Illustrative overview:

Browse in-depth TOC on "Urology Devices Market"

159 - Tables

44 - Figures

274 – Pages

North America is the largest regional market for urology devices market.

The market for urology devices has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the urology devices market. This can be attributed to the region's advanced healthcare facilities and substantial healthcare investments, which are pivotal in fueling the requirement for urology devices. Moreover, the projected rise in urological procedures is anticipated to contribute to the expansion of the market. As the demand for urological procedures rises, so does the need for precise urological devices to ensure successful and safe procedures.

Request Sample Pages:

Urology Devices Market Dynamics:

Drivers:

Rising incidence of urological diseases

Growing preference for minimally invasive procedures

Rising focus on R&D and product launches

Growing number of hospitals and surgical centers

Restraints:

High degree of consolidation among key players

Opportunities:

Growing Potential growth opportunities in emerging economies

Technological advancements

Challenge:

Increasing number of product recalls by key players

Shortage of skilled urologists

Key Market Players of Urology Devices Industry:

The major players operating in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).

Get 10% Free Customization on this Report:

Urology Devices Market Recent Developments:

In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.

In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.

In May 2022, B. Braun SE (Germany) entered into a distribution agreement, and B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.

In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)

In April 2021, Becton, Dickinson and Company (US) announced an investment of USD 65 million for the construction of a state-of-the-art medical facility in Tucson, Arizona (US), which will serve as a final stage manufacturing and sterilization center to improve overall efficiency, customer service, and supply chain in the US.

Urology Devices Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Rising incidence of urological diseases, growing preference for minimally invasive procedures, rising focus on R&D and product launches, growing number of hospitals and surgical centers), restraints (high degree of consolidation among key players), opportunities (potential growth opportunities in emerging economies, technological advancements) and challenges (increasing number of product recalls by key players, shortage of skilled urologists) influencing the growth of the urology devices market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urology devices market.

Market Development: Comprehensive information about lucrative markets – the report analyses the urology devices market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.

[sjsuraj]

Viscosupplementation Market: Innovations, Growth Trends, and Projections to 2033

The global Viscosupplementation Market size was valued at USD 3275.4 million in 2023 and is projected to reach USD 5938.3 million by 2031, growing at a CAGR of 7.91% from 2024 to 2031. 

This comprehensive research study on the global Viscosupplementation market offers detailed analyses of market trends, prominent drivers, and future growth prospects, providing readers with an extensive understanding of the market environment necessary for informed business decisions. Covering various aspects such as estimated market sizing, strategies employed by leading companies, restraining factors, and challenges faced by market participants, the report equips stakeholders with actionable insights.

Get a New Look of Sample PDF: https://www.kingsresearch.com/request-sample/viscosupplementation-market-692

Market Forecast and Trends

Precise market forecasts and identification of emerging trends enable stakeholders to anticipate the industry’s future trajectory and develop strategic tactics accordingly, providing a competitive edge in a dynamic business landscape.

Regional and Segment Analysis

The study facilitates industry participants in identifying high-growth regions and profitable market segments through region-specific and segment-by-segment analysis. This information aids in devising effective marketing strategies and product lineups tailored to the preferences and needs of diverse target audiences across major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Investment and Expansion Opportunities

The research report unveils prospective areas for investment and business growth in the global Viscosupplementation market, enabling strategic decision-making for readers seeking to expand into new markets or introduce new products.

Competitive Analysis

In-depth competitive analysis profiles major market competitors and evaluates their strategies, weaknesses, and market shares. Insights into top business strategies employed by key players such as partnerships, alliances, mergers, acquisitions, product innovations, and development empower industry participants to benchmark their businesses against rivals and devise winning strategies for market differentiation.

List of Key Companies in Viscosupplementation Market

Sanofi S.A.

Zimmer Biomet

Bioventus

Anika Therapeutics Inc.

Fidia Farmaceutici S.p.A.

Ferring B.V.

Seikagaku Corporation

Johnson & Johnson Medtech

OrthogenRx, Inc.

Chugai Pharmaceutical Co., Ltd.

Reasons to Purchase This Report:

Futureproof Decisions: Gain precise market forecasts and identify emerging trends to confidently navigate the future of the Viscosupplementation market.

Competitive Advantage: Outperform rivals with a comprehensive competitive analysis, revealing their strategies and market share.

Growth Catalysts Exposed: Uncover the key factors driving market expansion and leverage them to propel your business forward.

Profitable Opportunities: Pinpoint high-growth regions and lucrative market segments through in-depth regional and segment analysis.

Investment Guidance: Strategically plan investments and expansions in the global Viscosupplementation market with insights on potential growth areas.

Informed Decisions: Utilize precise market forecasts and in-depth analysis to make data-driven business decisions.

Market Expertise: Deepen your understanding of market trends and growth drivers for a comprehensive market landscape overview.

Actionable Insights: Gain practical takeaways from the report's competitive analysis, market sizing, and future projections.

The Global Viscosupplementation Market is Segmented as:

By Product

Single Injection

Three Injection

Five Injection

By End-user

Orthopedic Clinics/ASCs

Hospitals

By Region

North America

U.S.

Canada

Mexico

Europe

France

U.K.

Spain

Germany

Italy

Russia

Rest of Europe

Asia-Pacific

China

Japan

India

South Korea

Rest of Asia-Pacific

Middle East & Africa

GCC

North Africa

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

[wellnessweb]

Cleanroom Technologies Market Size Forecast to Expand in 2024

The Cleanroom Technologies Market Size was valued at USD 8.1 billion in 2023 and is expected to reach USD 13.81 billion by 2031 and grow at a CAGR of 6.9% over the forecast period 2024-2031.Exploring the growth trajectory of the cleanroom technologies market reveals a dynamic landscape shaped by evolving standards and technological advancements. This niche sector, crucial across industries like pharmaceuticals, biotechnology, and electronics, is witnessing robust expansion driven by stringent regulatory requirements and the escalating demand for contamination-free environments. As companies vie to maintain impeccable manufacturing standards and ensure product integrity, innovations in cleanroom design, HVAC systems, and monitoring technologies are pivotal. The market's upward trajectory is further propelled by increasing investments in healthcare infrastructure globally, underscoring its pivotal role in safeguarding critical processes and fostering reliable production outcomes. Amidst these trends, market players are navigating towards sustainable practices and flexible solutions, underscoring a pivotal shift towards efficiency and adaptability in cleanroom operations.

Get Sample of This Report @  https://www.snsinsider.com/sample-request/2245

Market Scope & Overview

The worldwide Cleanroom Technologies Market  research report includes an in-depth analysis of key market trends, company profiles, important product specifications, sales statistics, and contact information. Customers can get quantitative industry expertise by examining the most recent market data. The market research report delves deeply into the most important market trends.

During Cleanroom Technologies Market research, the impact of significant market variables such as motivators, restraints, opportunities, and threats on the industry is investigated. The underlying drivers and constraints influence global market opportunities and issues. Strategic collaborations, new product releases, initiatives, key market rivals, development factors, restrictions, and opportunities are all covered in market research.

Market Segmentation Analysis

By Product

Equipment

Fan filter

HVAC

Vacuum System

Consumables

Safety

Disinfectants

By Type

Standard Modular

Hardwall

Softwall

Mobile

By End User

Pharma

Biotech

Medtech

Hospitals

COVID-19 Impact Analysis

Participants in the market will benefit from this section of the research's representation of the market environment as a result of the COVID-19 epidemic now and in the future. The research investigates the impact of COVID-19 on global and national Cleanroom Technologies Market. The COVID-19 impact analysis will aid market participants in developing pandemic mitigation policies. This study considers the demand and supply side effects of the target market. This study relied on primary and secondary research, as well as private databases and a paid data source.

Regional Outlook

The performance of various regional markets in Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa was examined in the Cleanroom Technologies Market research report. Data was gathered through focus groups, questionnaires, interviews, national and geographic research, and an all-dimensional review.

Competitive Analysis

The study investigates a wide range of critical aspects influencing firm stakeholders such as suppliers, end users, dealers, and others in order to assist them in planning investments and pursuing various Cleanroom Technologies Market growth prospects. Market, prices, positioning, primary rivals, and a comprehensive data collection plan must all be consistent. The market report also includes a wide range of future market estimates based on historical data.

Key Reasons to Purchase Cleanroom Technologies Market Report

Extensive market research that considers downstream production, upstream raw materials, and current growth expectations.

Provide a basic overview of the present state of the target industry, including applications and advancements.

Conclusion

Emerging market global business research is available, including competitive landscape studies and development trends. This market research report is an excellent resource for market participants seeking to propel their businesses to success.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Angioplasty Balloon Market Analysis

Animal Genetic Market Analysis

Animal Model Market Analysis

Antibody Production Market Analysis

Anti coagulation Market Analysis

[imrmarket]

Surgical Sutures Market Set To Reach USD 7.56 Billion By 2032|Says IMR

Surgical Sutures Market Size Was Valued at USD 4.2 Billion in 2023 and is Projected to Reach USD 7.56 Billion by 2032, Growing at a CAGR of 6.75% From 2023-2032.

Market Overview:

The Surgical Sutures Market involves the manufacturing, distribution, and use of sutures, which are medical devices used to close wounds and surgical incisions. Sutures play a vital role in wound healing by bringing tissue edges together and promoting natural healing processes. This market encompasses a wide range of suture types, including absorbable and non-absorbable sutures, as well as various materials such as silk, nylon, polyester, and polypropylene. Surgical sutures are used across a broad spectrum of surgical specialties, including general surgery, orthopedics, obstetrics, gynecology, cardiovascular surgery, and ophthalmology.

Market Driver:

A key driver for the Surgical Sutures Market is the increasing number of surgical procedures worldwide. As the global population grows and ages, the demand for surgical interventions to treat various medical conditions continues to rise. Surgical sutures are indispensable tools in surgical practice, used for wound closure, tissue approximation, and hemostasis in a wide range of procedures. Additionally, advancements in surgical techniques and technologies have led to an expansion of the types and applications of surgical sutures, further driving market growth.

Market Opportunity:

An opportunity in the Surgical Sutures Market lies in the development of innovative suture materials and delivery systems that offer enhanced performance and patient outcomes. Manufacturers are investing in research and development to create sutures with improved tensile strength, knot security, flexibility, and biocompatibility. There is also a growing demand for sutures with antimicrobial coatings or additives to reduce the risk of surgical site infections. Furthermore, expanding access to surgical care in emerging markets presents opportunities for market expansion and penetration.

Key Companies:

Medtronic Plc (Europe),Johnson & Johnson Services Inc. (United States),B. Braun Melsungen AG(Europe),Boston Scientific Corporation (United States),Surgical Specialties Corporation (United States),Smith & Nephew Plc (United Kingdom),Derma Sciences (United States),Assut Medical Sarl (Europe),Advanced Medical Solutions Group Plc (United Kingdom),Stryker Corporation (United States),Ethicon, Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic Plc (Ireland), B. Braun SE (Germany), Advanced Medical Solutions Group Plc (UK),Internacional Farmacéutica S.A. de C.V. (Mexico),Healthium MedTech Limited (India), Peters Surgical (France),Corza Medical (US),DemeTECH Corporation (US), Zimmer Biomet Holdings Inc. (US),Stryker Corporation (US), Smith & Nephew Plc (UK), CONMED Corporation (US),Mellon Medical B.V. (Netherlands), Unisur Lifecare Pvt. Ltd. (India).

Request Methodology Now: https://introspectivemarketresearch.com/request/16519

By Product

Suture Thread

Automated Suturing Devices

By Type

Absorbable

Non-Absorbable

By Form

Natural

Synthetic

By Application

Cardiovascular Surgery

General Surgery

Gynecological Surgery

Orthopedic Surgery

Ophthalmic Surgery

By Filament

Monofilament

Multifilament

By Distribution channel

Pharmacies and Medical Stores

Online Retailers

Distributors and Wholesalers

By End-User

Hospitals

Ambulatory Surgical Centers

Inquiry before purchasing: https://introspectivemarketresearch.com/inquiry/16519

By Region

·         North America (U.S., Canada, Mexico)

(Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)

(Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)

(China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)

(Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)

(Brazil, Argentina, Rest of SA)

Scope

Extensive coverage of the sutures market under development.

An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

Reviews of major players involved in the development of the sutures market and lists all their pipeline projects.

Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

Key clinical trial data of ongoing clinical trials specific to pipeline products.

Recent developments in the segment/industry.

Purchase this report: https://introspectivemarketresearch.com/checkout/?user=1&_sid=16519

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assisting our clients to grow and have a successful impact on the market. Our team at IMR is ready to assist our clients to flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, that specializes in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1049

Email:sales@introspectivemarketresearch.com

LinkedIn | Twitter | Facebook

[wi4corporation]

A Brief Insight Into the Ever-Evolving Nature of SaMD Compliances and Their Significance in Europe

🏥💻 Dive into the complexities of Software as a Medical Device (SaMD) and European data laws. From patient privacy to regulatory nuances, discover key insights for success. 🚀🔒

Read the full blog here: https://wi4.org/news/insights/how-to-bring-samd-medtech-to-european-markets-a-patient-data-and-eu-compliance-perspective/

SaMD #DataPrivacy #InvestmentInsights #HealthTech #Wi4 #vineetagrawal

[janetushar1]

Varicose Veins Treatment Market to Hit $491.09 Million by 2032

The global Varicose Veins Treatment Market was valued at USD 298.98 Million in 2024 and it is estimated to garner USD 491.09 Million by 2032 with a registered CAGR of 6.4% during the forecast period 2024 to 2032.

Are you looking for the Varicose Veins Treatment Market Research Report? You are at the right place. If you desire to find out more data about the report or want customization, Contact us. If you want any unique requirements, please allow us to customize and we will offer you the report as you want.

The global Varicose Veins Treatment Market can be segmented on the basis of product type, Applications, distribution channel, market value, volume, and region [North America, Europe, Asia Pacific, Latin America, Middle East, and Africa]. The Varicose Veins Treatment Industry 2024 report provides a comprehensive overview of critical elements of the industry including drivers, restraints, and management scenarios.

Download Sample PDF: @ https://www.vantagemarketresearch.com/varicose-veins-treatment-market-1737/request-sample

Top Players

Medtronic PLC (Ireland), AngioDynamics Inc. (U.S.), Biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton S.R.L. (Italy), Vascular Solutions Inc. (U.S.), Quanta System S.P.A. (Italy), Sciton Inc. (U.S.), Fotona D.O.O. (Slovenia), BTG PLC (U.K.), Merz Aesthetics (U.S.), and others.

Trending 2024: Varicose Veins Treatment Market Report Highlights:

A comprehensive assessment of the parent Industry

Development of key aspects of the business

A study of industry-wide market segments

Evaluation of market value and volume in past, present, and future years

Evaluation of market share

Tactical approaches of market leaders

Innovative strategies that help companies to improve their position in the market

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/varicose-veins-treatment-market-1737/0

Analysis Of The Top Companies, Product Types, and Applications In The Market Report:

This report provides sales, revenue growth rate, and verified information about the major players. Also includes a regional analysis and a labor cost analysis, tables, and figures. It also highlights characteristics such as technological growth. The product type segment is expected to continue to maintain its leading position in the future and capture a significant market share based on sales. This report provides analysis, discussion, forecast, and debate on key industry trends, market share estimates, Industry size, and other information. This report also discusses drivers, risks, and opportunities.

Global Varicose Veins Treatment Market report contains detailed data and analysis on the Varicose Veins Treatment Market drivers, restraints, and opportunities. Experts with market and industry knowledge as well as research experience from regional experts validate the report. The Varicose Veins Treatment Market report provides forecast, historical and current revenue for each industry, region, and end-user segment.

Regions Included

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

Global Varicose Veins Treatment Market report data will help you make more informed decisions. For example, in relation to prices, distribution channels are means of marketing or identifying opportunities to introduce a new product or service. These results will also help you make more informed decisions about your existing operations and activities.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/varicose-veins-treatment-market-1737

You Can Use The Varicose Veins Treatment Market Report To Answer The Following Questions:

What are the growth prospects of the Varicose Veins Treatment Market business?

Who are the key manufacturers in the Varicose Veins Treatment Market space?

What Forecast Period for Global Varicose Veins Treatment Industry Report?

What are the main segments of the global Varicose Veins Treatment Market?

What are the key metrics like opportunities and market drivers?

The Varicose Veins Treatment Market Insights

Product Development/Innovation: Detailed Information On Upcoming Technologies, R&D Activities, And Product Launches In The Market.

Competitive Assessment: In-Depth Assessment Of Market Strategies, Geographic And Business Segments Of Key Market Players.

Market Development: Comprehensive Information On Emerging Markets. This Report Analyzes The Market For Different Segments In Different Regions.

Market Diversification: Comprehensive Information On New Products, Untapped Regions, Latest Developments, And Investments In The Varicose Veins Treatment Market.

Check Out More Reports

Global HIV Drugs Market:  Report Forecast by 2032

Global Herbal Supplements Market: Report Forecast by 2032

Global Vegetable Oil Market: Report Forecast by 2032

Global Power Bank Market: Report Forecast by 2032

Global Cable Assembly Market: Report Forecast by 2032

[ankit2396]

Ureteroscope Market Segmentation, Research Methodology And Revenue Growth Forecast Till 2030

Global Ureteroscope Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.

Get a Sample Copy of the Report at – https://www.fortunebusinessinsights.com/ureteroscope-market-103455

The global ureteroscope market size was valued at USD 981.8 million in 2019 and is projected to reach USD 1,498.1 million by 2027, exhibiting a CAGR of 5.5% during the forecast period. 

Drivers & Restraints

Growing prevalence of urolithiasis and urolithial cancer, increasing adoption of minimally invasive procedures, growing healthcare spending, and increasing innovations in product designs are projected to drive the market growth. For example, in April 2019, Dornier MedTech announced launch of New AXIS single-use flexible digital ureteroscopes at the American Urology Association Annual Meeting. This single- use product is designed to avoid cross contamination between patients by offering a clean and sterile ureteroscope for every patient, every time. Urinary stone disease is a rising concern globally, with estimated prevalence of 15%. Changes in lifestyle, growing consumption of alcohol, global warming, and improper diet are projected to contribute to rising incidence of urinary calculi.

This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Ureteroscope Market report.

This report focuses on Ureteroscope Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ureteroscope Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.

[moremedtech]

Medtech company MedAlliance acquired by Cordis for USD 1.135 billion

Medtech company MedAlliance acquired by Cordis for USD 1.135 billion. MedAlliance DEB technology Cordis GENEVA, Oct. 2, 2023 - Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of $35M and a 2023 upfront closing payment of $200M, together with regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029, for a total consideration of up to $1.135 Billion. Cordis is a worldwide leader in the development and manufacture of interventional cardiovascular and endovascular technologies. MedAlliance's innovative and revolutionary sustained sirolimus drug-eluting balloon (DEB) program, SELUTION SLR™ (Sustained Limus Release), has provided a flagship product family which complements Cordis' existing product portfolio, together with their sales, marketing and distribution expertise. Cordis customers will benefit from the extensive clinical study program and publication plan that have been executed by MedAlliance to further Cordis' heritage of bringing innovative products to patients. "The Cordis acquisition will accelerate access to this breakthrough technology for patients around the globe suffering from coronary and peripheral disease," said Jeffrey B. Jump, Founder, Chairman and CEO of MedAlliance. "I want to thank our entire MedAlliance team – including physicians, distributors and clinical patients who have succeeded in disrupting the coronary and peripheral markets to provide a safe and effective new technology. The arsenal of SELUTION SLR™ DEB clinical data is designed to change medical practice and improve patient outcomes." "Nearly twenty years ago, Cordis introduced CYPHER®, the first drug-eluting stent, transforming cardiovascular treatment for patients around the world," said Shar Matin, Cordis CEO. "As a newly independent company, we are beyond proud to further our legacy of innovation and market disruption with MedAlliance and the first MicroReservoir sirolimus drug-eluting balloon, SELUTION SLR." "We are excited to report on the positive SELUTION SLR data to date, with first-hand experience of the impressive clinical outcomes from patients treated with SELUTION SLR in Japan, India, Europe, and South America. We are now leading the effort to emulate these results in the United States. This technology has the distinct opportunity to change the treatment paradigm for patients suffering from cardiovascular and peripheral vascular disease," commented George Adams, Principal Investigator of the US SELUTION4SFA IDE study; Director, Cardiovascular and Peripheral Vascular Research; Rex Hospital Inc., Raleigh, North Carolina, United States. SELUTION SLR was awarded CE Mark Approval for the treatment of peripheral artery disease in February 2020 and for the treatment of coronary artery disease in May 2020 MedAlliance was the first drug-eluting balloon company to receive FDA Breakthrough Designation status. In addition to the BTK and superficial femoral artery (SFA) indications for which the company received FDA IDE approval in May and August 2022, MedAlliance received coronary in-stent restenosis (ISR) IDE approval in October 2022 and de novo coronary artery lesions approval in January 2023. Subsequent to achieving IDE Status, three FDA studies involving SELUTION SLR are currently enrolling with a fourth, involving patients with coronary de novo artery disease, planned to start in the next few weeks. The latter will complement the substantial experience gained with the ground-breaking SELUTION DeNovo trial in Europe, which has now enrolled over 1,660 patients, half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using SELUTION SLR versus any limus drug-eluting stent . This study is designed to change medical practice, as the majority of de novo coronary lesions are currently treated with a permanent metallic stent.

MedAlliance DEB technology

MedAlliance's unique DEB technology involves MicroReservoirs which contain a mixture of biodegradable polymer intermixed with the anti-restenotic drug sirolimus applied as a coating on the surface of an angioplasty balloon. These MicroReservoirs provide controlled and sustained release of the drug for up to 90 days. MedAlliance's proprietary CAT™ (Cell Adherent Technology) enables the MicroReservoirs to be coated onto balloons and efficiently transferred to adhere to the vessel lumen when delivered via expansion of the balloon. SELUTION SLR is commercially available in Europe, Asia, the Middle East, and the Americas (outside USA) and most other countries where the CE Mark is recognized. Over 40,000 units have been used for patient treatments in routine clinical practice or as part of coronary clinical trials.

Cordis

Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technologies with a more than 60-year history of pioneering breakthrough therapies to treat millions of patients. With a reputation for clinical acumen, training, and service, Cordis has a legacy of innovation in high-quality and minimally invasive cardiovascular products, building a strong global footprint with operations in more than 70 countries around the world. Read the full article